Sort
46,585 grants matching “heart failure”
Mechanistic insights into HIV-mediated heart failure with preserved ejection fraction
$646,794Hossein Ardehali · Northwestern University At Chicago · R01 · FY2020 · HL
Mechanistic insights into HIV-mediated heart failure with preserved ejection fraction
$646,794Hossein Ardehali · Northwestern University At Chicago · R01 · FY2021 · HL
A Cardiometabolic Health Program LINKED with Clinical-Community Support and Mobile HEAlth TelemonitoRing in PopulaTionS (LINKED-HEARTS PROGRAM)
$646,794Yvonne Commodore-Mensah · Johns Hopkins University · P50 · FY2025 · MD
Mechanistic insights into HIV-mediated heart failure with preserved ejection fraction
$646,794Hossein Ardehali · Northwestern University At Chicago · R01 · FY2018 · HL
Caregiver Stress: Interventions to Promote Health and Wellbeing
$646,691Elizabeth J Corwin · Emory University · P01 · FY2012 · NR
Kidney Injury in Patients with Acute Decompensated Heart Failure
$646,679Nisha Bansal · University Of Washington · R01 · FY2023 · DK
Multiscale Models for Predicting Short and Long-term Outcome of Cardiac Resynchronization Therapy
$646,665Kenneth C Bilchick · University Of Virginia · R01 · FY2022 · HL
First-in-Human Use of an Artificial Lung for Ambulatory Respiratory Support
$646,653Bartley Perry Griffith · University Of Maryland Baltimore · R01 · FY2017 · HL
Developing Long Noncoding RNA Therapy for Precision Cardiac Repair
$646,621Ke Cheng · Columbia Univ New York Morningside · R01 · FY2024 · HL
Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension
$646,539Javid J Moslehi · University Of California, San Francisco · R01 · FY2023 · HL
Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension
$646,539Javid J Moslehi · University Of California, San Francisco · R01 · FY2022 · HL
Development of P2Y Receptor Ligands
$646,531Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity
$646,527Aarti Asnani · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL
Cell Therapy in Hypertrophied and Remodeled Left Ventricle
$646,454Jianyi Zhang · University Of Alabama At Birmingham · R01 · FY2017 · HL
Machine learning for the automated identification and tracking of rare myocardial diseases
$646,449Calum A. Macrae · Brigham And Women'S Hospital · R01 · FY2021 · HL
3D Cine Magnetic Resonance Fingerprinting for Rapid Phenotyping of Cardiomyopathy
$646,399Imran Rashid · Case Western Reserve University · R01 · FY2024 · HL
Predicting and preventing drug metabolism by the human gut microbiome
$646,398Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2023 · HL
Fibroblast targeting for myocardial repair
$646,395Francis G Spinale · University Of South Carolina At Columbia · R01 · FY2024 · HL
Mechanical Stress-Dependent Remodeling of the Cardiac Microtubule Network
$646,388Kenneth Ber Margulies · University Of Pennsylvania · R01 · FY2024 · HL
Chronic Antibody-Mediated Rejection of Kidney Allografts
$646,362Robert Fairchild · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · AI
Chronic Antibody-Mediated Rejection of Kidney Allografts
$646,362Robert Fairchild · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · AI
Chronic Antibody-Mediated Rejection of Kidney Allografts
$646,362Robert Fairchild · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · AI
Use of advanced imaging techniques to improve diagnostic methods for ARDS
$646,344Ednan K. Bajwa · Massachusetts General Hospital · R01 · FY2014 · HL
Biventricular Pacing After Cardiopulmonary Bypass
$646,329Henry Michael Spotnitz · Columbia University Health Sciences · R01 · FY2008 · HL
YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses
$646,307Zhiqiang Lin · Masonic Medical Research Laboratory, Inc · R01 · FY2023 · HL